Quarterly report pursuant to Section 13 or 15(d)

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details)

v3.24.3
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Business Acquisition, Contingent Consideration [Line Items]    
Deferred income - ERC $ 10,140 $ 10,140
Goods received not invoiced 5,221 5,019
Accrued employee related expenses and liabilities 5,225 4,175
Operating lease obligations $ 4,641 $ 4,693
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total accrued expenses and other current liabilities Total accrued expenses and other current liabilities
Accrued sales and excise taxes $ 1,791 $ 2,388
Accrued interest 1,529 4,106
Deferred revenue (loyalty program) 1,320 1,407
Accrued capital expenditures 739 702
Accrued professional and management fees 398 986
Other accrued expenses and current liabilities 4,765 5,470
Total accrued expenses and other current liabilities 35,769 44,070
Nature's Remedy    
Business Acquisition, Contingent Consideration [Line Items]    
Other liabilities - non-current 5,000  
Interest payable, noncurrent 3,030  
Acquisition Milestone Accrual    
Business Acquisition, Contingent Consideration [Line Items]    
Contingent consideration liabilities 0 4,167
Thirty-Month Anniversary Contingent Consideration    
Business Acquisition, Contingent Consideration [Line Items]    
Contingent consideration liabilities $ 0 $ 817